http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006098332-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd569fbfa1953ca9b7b375510e4d2763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61219e2a07aa7d41dd838bc98fdbce01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f844f6603dfe3eee847e0682e24fd0a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
filingDate 2006-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58872e69a435888c6efc648836a22418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2f1281a8584e20ba78bdbd9fe433740
publicationDate 2006-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006098332-A1
titleOfInvention Promoter for hard tissue formation
abstract Disclosed is an agent which can act on a cell directly to induce the promotion of hard tissue formation, the promotion of cell differentiation and the enhancement of the cellular alkaline phosphatase activity. Specifically, disclosed is a promoter for hard tissue formation, an inducer for cell differentiation or an enhancer for cellular alkaline phosphatase activity comprising a glycosaminoglycan having a sulfate group and possessing the following properties (1) and (2) or a salt thereof as the active ingredient: (1) it has, as the structural basis, a disaccharide repeated structure composed of a hexuronate residue and a glucosamine residue; and (2) in the structural basis of (1), any one or less of the hydroxyl group at position 2 of the hexuronate residue, the hydroxyl group at position 6 of the glucosamine residue or the amino group at position 2 of the glucosamine residue has no sulfate group. The hexuronate residue is preferably a glucuronate residue or iduronate residue.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016520697-A
priorityDate 2005-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004210715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004505124-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10231251-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000212204-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129452469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129452471

Total number of triples: 44.